83 related articles for article (PubMed ID: 12718723)
1. Shifting emphasis from pharmacogenomics to theragnostics.
Ozdemir V; Williams-Jones B; Glatt SJ; Tsuang MT; Lohr JB; Reist C
Nat Biotechnol; 2006 Aug; 24(8):942-6. PubMed ID: 16900136
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics and drug development.
Guo Y; Shafer S; Weller P; Usuka J; Peltz G
Pharmacogenomics; 2005 Dec; 6(8):857-64. PubMed ID: 16296948
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics and the future of medical practice.
Lindpaintner K
Br J Clin Pharmacol; 2002 Aug; 54(2):221-30. PubMed ID: 12207645
[TBL] [Abstract][Full Text] [Related]
4. Criteria influencing the clinical uptake of pharmacogenomic strategies.
Shah J
BMJ; 2004 Jun; 328(7454):1482-6. PubMed ID: 15205293
[TBL] [Abstract][Full Text] [Related]
5. Pediatrics in 21
Singh M
Indian J Pediatr; 2016 Nov; 83(12-13):1420-1425. PubMed ID: 27510612
[TBL] [Abstract][Full Text] [Related]
6. An Integrated Transcriptomic Approach to Identify Molecular Markers of Calcineurin Inhibitor Nephrotoxicity in Pediatric Kidney Transplant Recipients.
Rhone ET; Bardhi E; Bontha SV; Walker PD; Almenara JA; Dumur CI; Cathro H; Maluf D; Mas V
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063776
[TBL] [Abstract][Full Text] [Related]
7. No population left behind: Improving paediatric drug safety using informatics and systems biology.
Giangreco NP; Elias JE; Tatonetti NP
Br J Clin Pharmacol; 2022 Feb; 88(4):1464-1470. PubMed ID: 33332641
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.
Lee EM; Xu K; Mosbrook E; Links A; Guzman J; Adams DR; Flynn E; Valkanas E; Toro C; Tifft CJ; Boerkoel CF; Gahl WA; Sincan M
Genet Med; 2016 Dec; 18(12):1303-1307. PubMed ID: 27253732
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.
Khan LM; Al-Harthi SE; Saadah OI
Saudi Pharm J; 2013 Jul; 21(3):261-6. PubMed ID: 23960842
[TBL] [Abstract][Full Text] [Related]
10. Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay--a systematic review.
Khan LM
Eur J Clin Pharmacol; 2013 Dec; 69(12):1985-96. PubMed ID: 23955174
[TBL] [Abstract][Full Text] [Related]
11. Using pharmacogenetics to understand adverse drug reactions in children.
Shaw K; Amstutz U; Carleton BC
Paediatr Child Health; 2011 Nov; 16(9):537-8. PubMed ID: 23115490
[No Abstract] [Full Text] [Related]
12. Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.
Wagner J; Leeder JS
Pediatr Clin North Am; 2012 Oct; 59(5):1017-37. PubMed ID: 23036242
[TBL] [Abstract][Full Text] [Related]
13. Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.
Russo R; Capasso M; Paolucci P; Iolascon A;
Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():17-27. PubMed ID: 21069522
[TBL] [Abstract][Full Text] [Related]
14. Maternal-fetal and neonatal pharmacogenomics: a review of current literature.
Blumenfeld YJ; Reynolds-May MF; Altman RB; El-Sayed YY
J Perinatol; 2010 Sep; 30(9):571-9. PubMed ID: 19924131
[TBL] [Abstract][Full Text] [Related]
15. Researchers' perceptions of the ethical implications of pharmacogenomics research with children.
Avard D; Silverstein T; Sillon G; Joly Y
Public Health Genomics; 2009; 12(3):191-201. PubMed ID: 19204423
[TBL] [Abstract][Full Text] [Related]
16. Developmental and pediatric pharmacogenomics.
Leeder JS
Pharmacogenomics; 2003 May; 4(3):331-41. PubMed ID: 12718723
[TBL] [Abstract][Full Text] [Related]
17. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond.
Leeder JS
Drug Discov Today; 2004 Jul; 9(13):567-73. PubMed ID: 15203092
[TBL] [Abstract][Full Text] [Related]
18. Asthma pharmacogenomics.
Hawkins GA; Weiss ST; Bleecker ER
Immunol Allergy Clin North Am; 2005 Nov; 25(4):723-42. PubMed ID: 16257635
[TBL] [Abstract][Full Text] [Related]
19. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
